Soumit Roy
Stock Analyst at Jones Trading
(3.17)
# 1,176
Out of 4,752 analysts
32
Total ratings
20%
Success rate
12.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics | Initiates: Buy | $32 | $5.74 | +457.49% | 1 | Jan 28, 2025 | |
| MURA Mural Oncology | Initiates: Buy | $16 | $3.69 | +333.60% | 1 | Jan 27, 2025 | |
| CRVO CervoMed | Downgrades: Hold | n/a | $2.30 | - | 2 | Dec 10, 2024 | |
| EPIX ESSA Pharma | Downgrades: Hold | n/a | $1.68 | - | 1 | Nov 1, 2024 | |
| ELTX Elicio Therapeutics | Initiates: Buy | $9 | $9.22 | -2.39% | 1 | Oct 31, 2024 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $36 | $22.00 | +63.64% | 1 | Oct 31, 2024 | |
| ORIC ORIC Pharmaceuticals | Initiates: Buy | $17 | $10.75 | +58.14% | 1 | Oct 31, 2024 | |
| BEAM Beam Therapeutics | Initiates: Hold | n/a | $25.75 | - | 1 | Sep 17, 2024 | |
| EDIT Editas Medicine | Initiates: Buy | $13 | $1.29 | +907.75% | 1 | Sep 17, 2024 | |
| ACET Adicet Bio | Maintains: Buy | $6 → $4 | $0.92 | +334.83% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.25 | - | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.39 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.47 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $10.20 | +154.90% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $41.31 | +69.45% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $48.00 | -79.17% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $5.91 | +339.93% | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.72 | +1,155.23% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.65 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $12.08 | +562.25% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.27 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.54 | +1,370.59% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $5.01 | +16,067.66% | 1 | Feb 24, 2021 |
OnKure Therapeutics
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $5.74
Upside: +457.49%
Mural Oncology
Jan 27, 2025
Initiates: Buy
Price Target: $16
Current: $3.69
Upside: +333.60%
CervoMed
Dec 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.30
Upside: -
ESSA Pharma
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.68
Upside: -
Elicio Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $9.22
Upside: -2.39%
Enliven Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $36
Current: $22.00
Upside: +63.64%
ORIC Pharmaceuticals
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $10.75
Upside: +58.14%
Beam Therapeutics
Sep 17, 2024
Initiates: Hold
Price Target: n/a
Current: $25.75
Upside: -
Editas Medicine
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.29
Upside: +907.75%
Adicet Bio
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.92
Upside: +334.83%
Aug 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.25
Upside: -
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.39
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.47
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $10.20
Upside: +154.90%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $41.31
Upside: +69.45%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $48.00
Upside: -79.17%
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $5.91
Upside: +339.93%
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.72
Upside: +1,155.23%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.65
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $12.08
Upside: +562.25%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.27
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $8
Current: $0.54
Upside: +1,370.59%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $5.01
Upside: +16,067.66%